Medicenna Therapeutics Corp.
MDNAF
$0.31
-$0.02-7.02%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.30M | -13.28M | -9.41M | -9.99M | -9.50M |
| Total Depreciation and Amortization | 50.30K | 52.00K | 55.10K | 56.50K | 47.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.29M | -2.27M | -5.52M | -4.18M | -4.45M |
| Change in Net Operating Assets | 2.06M | 2.57M | 1.69M | 1.94M | 1.20M |
| Cash from Operations | -13.48M | -12.93M | -13.19M | -12.17M | -12.70M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -1.50K |
| Sale of Property, Plant, and Equipment | 1.40K | 1.40K | 1.40K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.40K | 1.40K | 1.40K | 0.00 | -1.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -78.00K | -71.00K | -70.00K | -51.00K | -32.00K |
| Issuance of Common Stock | 3.90M | 52.00K | 52.00K | 1.96M | 2.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -300.00K |
| Cash from Financing | 2.69M | -13.60K | -12.40K | 1.36M | 1.90M |
| Foreign Exchange rate Adjustments | 158.90K | -465.70K | -660.90K | 317.50K | -76.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.63M | -13.40M | -13.86M | -10.49M | -10.88M |